Literature DB >> 27771769

High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.

Xiaosheng He1,2, Xutao Lin1,2, Muyan Cai3,4, Dejun Fan1,2, Xiuting Chen1,2, Lei Wang1,2, Xiaojian Wu1,2, Ping Lan5,6, Jianping Wang7,8.   

Abstract

Cytoplasmic polyadenylation element-binding protein 4 (CPEB4), a zinc-finger-containing sequence-specific RNA-binding protein, has been associated with tumor proliferation, invasion, and migration. Expression of CPEB4 and its prognostic significance in human colorectal cancer (CRC) have not been studied. The aim of the present study was to investigate expression of CPEB4 and its prognostic significance in CRC. Expression of CPEB4 in CRC tissues from two independent cohorts was examined by immunohistochemistry. Prognostic significance was analyzed using receiver operating characteristic curve analysis, Kaplan-Meier curves, and Cox regression analysis. High expression of CPEB4 was observed in 14.8 % of CRCs in the training cohort and 12.2 % of CRCs in the validation cohort. High expression of CPEB4 was significantly correlated with the pM classification, TNM stage, and poorer overall survival in both cohorts. Through multivariate Cox regression analysis, high expression of CPEB4 was found to be an independent prognostic biomarker for overall survival in CRC patients. High expression of CPEB4 may be an independent and useful biomarker for predicting the poor survival of patients with CRC.

Entities:  

Keywords:  Biomarker; Colorectal cancer; Cytoplasmic polyadenylation element-binding proteins; Prognosis

Mesh:

Substances:

Year:  2016        PMID: 27771769     DOI: 10.1007/s00428-016-2037-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

1.  High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.

Authors:  Xian-Rui Wu; Xiao-Sheng He; Yu-Feng Chen; Rui-Xue Yuan; Yang Zeng; Lei Lian; Yi-Feng Zou; Nan Lan; Xiao-Jian Wu; Ping Lan
Journal:  J Surg Oncol       Date:  2012-01-27       Impact factor: 3.454

2.  A deadenylation negative feedback mechanism governs meiotic metaphase arrest.

Authors:  Eulàlia Belloc; Raúl Méndez
Journal:  Nature       Date:  2008-04-02       Impact factor: 49.962

3.  Control of cellular senescence by CPEB.

Authors:  Irina Groisman; Maria Ivshina; Veronica Marin; Norman J Kennedy; Roger J Davis; Joel D Richter
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

4.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

5.  CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion.

Authors:  Ming-Chung Kan; Aparna Oruganty-Das; Amalene Cooper-Morgan; Guang Jin; Sharon A Swanger; Gary J Bassell; Harvey Florman; Klaus van Leyen; Joel D Richter
Journal:  Mol Cell Biol       Date:  2010-10-11       Impact factor: 4.272

6.  Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.

Authors:  Christine Mayr; Michael T Hemann; David P Bartel
Journal:  Science       Date:  2007-02-22       Impact factor: 47.728

7.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

8.  CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer.

Authors:  Yifeng Zou; Yufeng Chen; Xianrui Wu; Ruixue Yuan; Zerong Cai; Xiaosheng He; Xinjuan Fan; Lei Wang; Xiaojian Wu; Ping Lan
Journal:  Oncol Rep       Date:  2013-06-11       Impact factor: 3.906

9.  PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation.

Authors:  Shengquan Huang; Qianjin Liao; Longkun Li; Dianqi Xin
Journal:  Tumour Biol       Date:  2014-03-14

10.  Key contribution of CPEB4-mediated translational control to cancer progression.

Authors:  Elena Ortiz-Zapater; David Pineda; Neus Martínez-Bosch; Gonzalo Fernández-Miranda; Mar Iglesias; Francesc Alameda; Mireia Moreno; Carolina Eliscovich; Eduardo Eyras; Francisco X Real; Raúl Méndez; Pilar Navarro
Journal:  Nat Med       Date:  2011-12-04       Impact factor: 53.440

View more
  4 in total

Review 1.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

2.  Investigation of the expression levels of CPEB4, APC, TRIP13, EIF2S3, EIF4A1, IFNg, PIK3CA and CTNNB1 genes in different stage colorectal tumors

Authors:  Zafer Söylemez; Evrim Suna Arıkan; Mustafa Solak; Yüksel Arıkan; Çiğdem Tokyol; Hüseyin Şeker
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

Review 3.  Post-transcriptional Regulation of Colorectal Cancer: A Focus on RNA-Binding Proteins.

Authors:  Jennyfer M García-Cárdenas; Santiago Guerrero; Andrés López-Cortés; Isaac Armendáriz-Castillo; Patricia Guevara-Ramírez; Andy Pérez-Villa; Verónica Yumiceba; Ana Karina Zambrano; Paola E Leone; César Paz-Y-Miño
Journal:  Front Mol Biosci       Date:  2019-08-07

4.  Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development.

Authors:  Annarita Sibilio; Clara Suñer; Marcos Fernández-Alfara; Judit Martín; Antonio Berenguer; Alexandre Calon; Veronica Chanes; Alba Millanes-Romero; Gonzalo Fernández-Miranda; Eduard Batlle; Mercedes Fernández; Raúl Méndez
Journal:  iScience       Date:  2022-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.